Valproate containing medicines – High risk of congenital abnormalities and development disorders

Valproate containing medicines – High risk of congenital abnormalities and development disorders

Aspen Pharmacare, Brimpharm SA (Pty) Ltd, Adcock Ingram Limited, Sandoz SA (Pty) Ltd and Takeda (Pty) Ltd in collaboration with the South African Health Products Regulatory Authority (SAHPRA) would like to inform you of the risks related to the use of valproate containing medicines (sodium valproate, valproic acid) during pregnancy and lactation.

2019 Apr

Download
File Type: pdf
Category: Communication To Health Care Professionals
Unit: pharmacovigilance